PMC Articles for MedGen (Select 859573) - PMC

Result Filters

Links from MedGen

Items: 19

Select item 79626021.

A Machine Learning-Based Model to Predict Survival After Transarterial Chemoembolization for BCLC Stage B Hepatocellular Carcinoma

Huapeng Lin, Lingfeng Zeng, Jing Yang, Wei Hu, Ying Zhu

Front Oncol. 2021; 11: 608260. Published online 2021 Mar 2. doi: 10.3389/fonc.2021.608260

PMCID:: PMC7962602

Abstract Article PDF–1.4M

Select item 37065922.

Comparison of Long-Term Survival of Patients with BCLC Stage B Hepatocellular Carcinoma after Liver Resection or Transarterial Chemoembolization

Jian-Hong Zhong, Bang-De Xiang, Wen-Feng Gong, Yang Ke, Qin-Guo Mo, Liang Ma, Xing Liu, Le-Qun Li

PLoS One. 2013; 8(7): e68193. Published online 2013 Jul 9. doi: 10.1371/journal.pone.0068193

Correction in:: PLoS One. 2014; 9(1): 10.1371/annotation/32a8c7e3-5efc-478b-b374-c8cbfd1d3968.

PMCID:: PMC3706592

Abstract Article PDF–286K

Select item 52915993.

Transcatheter Arterial Chemoembolization With Gelatin Sponge Microparticles Treated for BCLC Stage B Hepatocellular Carcinoma: A Single Center Retrospective Study

Asad Ullah Kamran, Ying Liu, Feng E. Li, Song Liu, Jian Lin Wu, Yue Wei Zhang

Medicine (Baltimore) 2015 Dec; 94(52): e2154. Published online 2015 Dec 31. doi: 10.1097/MD.0000000000002154

PMCID:: PMC5291599

Abstract Article PDF–307K

Select item 53204604.

Transcatheter arterial chemoembolisation (TACE) plus S-1 for the treatment of BCLC stage B hepatocellular carcinoma refractory to TACE

Wu-Kui Huang, Shu-Fa Yang, Li-na You, Mo Liu, Deng-Yao Liu, Peng Gu, Xi-Wen Fan

Contemp Oncol (Pozn) 2016; 20(6): 468–474. Published online 2017 Jan 12. doi: 10.5114/wo.2016.65607

PMCID:: PMC5320460

Abstract Article PDF–80K

Select item 60455115.

Combined transarterial chemoembolization and microwave ablation versus transarterial chemoembolization in BCLC stage B hepatocellular carcinoma

Rusi Zhang, Lujun Shen, Long Zhao, Zhaoming Guan, Qifeng Chen, Wang Li

Diagn Interv Radiol. 2018 Jul; 24(4): 219–224. Published online 2018 May 18. doi: 10.5152/dir.2018.17528

PMCID:: PMC6045511

Abstract Article PDF–611K

Select item 75507586.

Surveillance Strategy for Patients With BCLC Stage B Hepatocellular Carcinoma After Achieving Complete Remission: Data From the Real World

Ying Wu, Lujun Shen, Han Qi, Fei Cao, Shuanggang Chen, Lin Xie, Tao Huang, Danyang Zhou, Jinqing Mo, Weijun Fan

Front Oncol. 2020; 10: 574804. Published online 2020 Sep 29. doi: 10.3389/fonc.2020.574804

PMCID:: PMC7550758

Abstract Article PDF–1.2M

Select item 114134087.

Frontline evaluation: Atezolizumab–bevacizumab versus lenvatinib for BCLC stage B hepatocellular carcinoma exceeding the up‐to‐seven criteria

Masamichi Kimura, Koji Nishikawa, Jun Imamura, Kiminori Kimura

Cancer Med. 2024 Sep; 13(18): e70217. Published online 2024 Sep 20. doi: 10.1002/cam4.70217

PMCID:: PMC11413408

Abstract Article PDF–815K

Select item 83226898.

Efficacy and Prognostic Factors of Trans-Arterial Chemoembolization Combined With Stereotactic Body Radiation Therapy for BCLC Stage B Hepatocellular Carcinoma

Changchen Jiang, Shenghua Jing, Han Zhou, Aomei Li, Xiangnan Qiu, Xixu Zhu, Zetian Shen

Front Oncol. 2021; 11: 640461. Published online 2021 Jul 16. doi: 10.3389/fonc.2021.640461

PMCID:: PMC8322689

Abstract Article PDF–758K

Select item 92830549.

An ALBI- and Ascites-Based Model to Predict Survival for BCLC Stage B Hepatocellular Carcinoma

Cheng He, Jing Yang, Zheng Jin, Ying Zhu, Wei Hu, Lingfeng Zeng, Xiaocheng Li

Evid Based Complement Alternat Med. 2022; 2022: 1801230. Published online 2022 Jul 7. doi: 10.1155/2022/1801230

PMCID:: PMC9283054

Abstract Article PDF–1.6M

Select item 1022521410.

Impact of skeletal muscle volume on patients with BCLC stage‐B hepatocellular carcinoma undergoing sorafenib therapy

Issei Saeki, Takahiro Yamasaki, Yurika Yamauchi, Tomokazu Kawaoka, Shinsuke Uchikawa, Akira Hiramatsu, Hiroshi Aikata, Kazufumi Kobayashi, Takayuki Kondo, Sadahisa Ogasawara, Tetsuhiro Chiba, Reo Kawano, Kazuaki Chayama, Naoya Kato, Taro Takami

Cancer Med. 2023 May; 12(9): 10625–10635. Published online 2023 Mar 23. doi: 10.1002/cam4.5810

PMCID:: PMC10225214

Abstract Article PDF–609K

Select item 844740211.

Surveillance Strategy for Barcelona Clinic Liver Cancer B Hepatocellular Carcinoma Achieving Complete Response: An Individualized Risk-Based Machine Learning Study

Qi-Feng Chen, Lin Dai, Ying Wu, Zilin Huang, Minshan Chen, Ming Zhao

Front Bioeng Biotechnol. 2021; 9: 667641. Published online 2021 Aug 31. doi: 10.3389/fbioe.2021.667641

PMCID:: PMC8447402

Abstract Article PDF–1.6M

Select item 927909912.

Efficacy Investigation of TACE Combined with Lenvatinib and Sintilimab in Intermediate-Stage Hepatocellular Carcinoma

Menglong Zhang, Weiguo Lai, Jian Zhang, Bijuan Hu, Liyin Huang, Cunkun Chu

Dis Markers. 2022; 2022: 6957580. Published online 2022 Jul 6. doi: 10.1155/2022/6957580

Retraction in:: Dis Markers. 2023; 2023: 9791613.

PMCID:: PMC9279099

Abstract Article

Select item 769835713.

Real Life Prospective Evaluation of New Drug-Eluting Platform for Chemoembolization of Patients with Hepatocellular Carcinoma: PARIS Registry

Thierry de Baere, Boris Guiu, Maxime Ronot, Patrick Chevallier, Géraldine Sergent, Illario Tancredi, Lambros Tselikas, Marco Dioguardi Burgio, Lucas Raynaud, Frederic Deschamps, Gontran Verset

Cancers (Basel) 2020 Nov; 12(11): 3405. Published online 2020 Nov 17. doi: 10.3390/cancers12113405

PMCID:: PMC7698357

Abstract Article PDF–1.8M

Select item 714702614.

Comparison of overall survival on surgical resection versus transarterial chemoembolization with or without radiofrequency ablation in intermediate stage hepatocellular carcinoma: a propensity score matching analysis

Chih-Wen Lin, Yaw-Sen Chen, Gin-Ho Lo, Yao-Chun Hsu, Chia-Chang Hsu, Tsung-Chin Wu, Jen-Hao Yeh, Pojen Hsiao, Pei-Min Hsieh, Hung-Yu Lin, Chih-Wen Shu, Chao-Ming Hung

BMC Gastroenterol. 2020; 20: 99. Published online 2020 Apr 10. doi: 10.1186/s12876-020-01235-w

PMCID:: PMC7147026

Abstract Article PDF–970K

Select item 948060415.

Retrospective Study of the Efficacy and Safety of Chemoembolization with Drug-Eluting Microspheres Combined with Intra-Arterial Infusion of Bevacizumab for Unresectable Hepatocellular Carcinoma

Shota Ueda, Shinichi Hori, Atsushi Hori, Kazuhiro Makitani, Ke Wan, Tetsuo Sonomura

J Hepatocell Carcinoma. 2022; 9: 973–985. Published online 2022 Sep 12. doi: 10.2147/JHC.S380439

PMCID:: PMC9480604

Abstract Article PDF–2.1M

Select item 594039516.

Transarterial chemoembolization as a substitute to radiofrequency ablation for treating Barcelona Clinic Liver Cancer stage 0/A hepatocellular carcinoma

Kentaro Ishikawa, Tetsuhiro Chiba, Yoshihiko Ooka, Eiichiro Suzuki, Sadahisa Ogasawara, Takahiro Maeda, Masayuki Yokoyama, Masanori Inoue, Toru Wakamatsu, Yuko Kusakabe, Tomoko Saito, Akinobu Tawada, Makoto Arai, Tatsuo Kanda, Hitoshi Maruyama, Fumio Imazeki, Naoya Kato

Oncotarget. 2018 Apr 20; 9(30): 21560–21568. Published online 2018 Apr 20. doi: 10.18632/oncotarget.25108